Please enable Javascript
Maen Abdelrahim, MD, PhD
Maen Abdelrahim, MD, PhD, of Houston Methodist Neal Cancer Center
Articles by Maen Abdelrahim, MD, PhD
NAPOLI 3: UGT1A1*28 Polymorphism and Tolerability in Patients With mPDAC Treated With NALIRIFOX
Maen Abdelrahim, MD, PhD
Pancreatic Cancer
|
March 13, 2025
Dr. Abdelrahim details the impact of UGT1A1*28 polymorphism on tolerability in patients with mPDAC in the NAPOLI 3 study.
View More